Last reviewed · How we verify
Itraconazole capsule
Itraconazole capsule is a Small molecule drug developed by Advenchen Laboratories Nanjing Ltd.. It is currently FDA-approved. Also known as: Itraconazole, PUR1900, azole antifungal, CYP3A4 inhibitor (perpetrator drug).
At a glance
| Generic name | Itraconazole capsule |
|---|---|
| Also known as | Itraconazole, PUR1900, azole antifungal, CYP3A4 inhibitor (perpetrator drug), Icon |
| Sponsor | Advenchen Laboratories Nanjing Ltd. |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Clinical Trial in Healthy Participants to Learn How Itraconazole Affects MK-2828 Levels and How MK-2828 Affects Midazolam Levels (MK-2828-007) (PHASE1)
- Drug-drug Interaction Trial of AP31969 and Carbamazepine or Itraconazole (PHASE1)
- A Study Evaluating the Effects of Itraconazole or Rifampin on the Pharmacokinetic Characteristics of Rocbrutinib Tablet (PHASE1)
- Catequentinib Hydrochloride (AL3818) Drug-Drug Interaction Study in Healthy Volunteers (PHASE1)
- Drug Interaction and Food Effect Study of CS0159 (PHASE1)
- Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (PHASE1)
- A Study of the Effect of Itraconazole and Phenytoin on Calderasib (MK-1084) in Healthy Adults (MK-1084-008) (PHASE1)
- Histoplasmosis Induction and Consolidation Therapy Factorial Randomized Clinical Trial (Histo-FACT) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Itraconazole capsule CI brief — competitive landscape report
- Itraconazole capsule updates RSS · CI watch RSS
- Advenchen Laboratories Nanjing Ltd. portfolio CI
Frequently asked questions about Itraconazole capsule
What is Itraconazole capsule?
Itraconazole capsule is a Small molecule drug developed by Advenchen Laboratories Nanjing Ltd..
Who makes Itraconazole capsule?
Itraconazole capsule is developed and marketed by Advenchen Laboratories Nanjing Ltd. (see full Advenchen Laboratories Nanjing Ltd. pipeline at /company/advenchen-laboratories-nanjing-ltd).
Is Itraconazole capsule also known as anything else?
Itraconazole capsule is also known as Itraconazole, PUR1900, azole antifungal, CYP3A4 inhibitor (perpetrator drug), Icon.
What development phase is Itraconazole capsule in?
Itraconazole capsule is FDA-approved (marketed).
Related
- Manufacturer: Advenchen Laboratories Nanjing Ltd. — full pipeline
- Also known as: Itraconazole, PUR1900, azole antifungal, CYP3A4 inhibitor (perpetrator drug), Icon
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing